THNR ETF largest holding is NVO:OS at 9.35% as of Aug 10, 2026

THNR ETF largest holding is NVO:OS at 9.35% as of Aug 10, 2026
$26.46
See how much of THNR you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

NVO:OS is THNR's largest holding at 9.35% of the fund as of Aug 10, 2026. THNR is Amplify Weight Loss Drug & Treatment ETF.

Showing top 22 of 22 holdings · as of Aug 10, 2026
THNR holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1Novo-Nordisk A/S-Spons AdrHealth Care · Pharmaceuticals
9.35%
9.3%10,466$494.6KHealth CarePharmaceuticals
2
LLY
Eli Lilly & Co.Health Care · Pharmaceuticals
8.90%
18.3%397$470.7KHealth CarePharmaceuticals
Sector and industry · Pro
3
REGN
Regeneron Pharmaceuticals, Inc.
5.96%
24.2%402$315.3K
4Innovent Biologics, Inc.
5.83%
30.0%25,500$308.3K
5CSPC Pharmaceutical Group Limited Shs
5.44%
35.5%260,000$288.0K
6
AMGN
Amgen Inc.
5.39%
40.9%694$285.2K
7
SRRK
Scholar Rock Holding Corp
5.34%
46.2%5,340$282.6K
8
ARWR
Arrowhead Pharmaceuticals Inc
5.31%
51.5%3,207$281.1K
9
RO
Roche Holding Ltd. Ordinary Shares - Bearer Shares
5.20%
56.7%605$274.9K
10
ABBV
AbbVie Inc.
4.94%
61.7%1,062$261.3K
11
HIMS
Hims & Hers Health Inc
4.93%
66.6%8,264$261.1K
12
MRK
Merck & Company Inc
4.80%
71.4%1,977$254.2K
13
PFE
Pfizer Inc
4.74%
76.1%9,377$250.9K
14
VKTX
Viking Therapeutics Inc
4.69%
80.8%7,239$248.0K
15Chugai Pharmaceutical Co. Ltd. Com Stk
4.19%
85.0%5,100$221.4K
16Developed Markets Astrazeneca Plc Sponsored Adr
4.11%
89.1%1,348$217.6K
17
ZEAL
Zealand Pharma A/S Ordinary Shares
3.91%
93.0%4,047$207.0K
18Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
2.23%
95.3%15,800$117.8K
19Hanmi Pharm Co Ltd
2.10%
97.4%402$111.3K
20
KLRA
Kailera Therapeutics Inc
2.02%
99.4%5,732$107.0K
21
AGPXX
Invesco Government & Agency Portfolio, Institutional Class
0.37%
99.7%19,616$19.6K
22DebtFreddie Mac Pool
0.24%
100.0%12,766$12.8K
Not reported for this fund: share changes.
FundXLS Pro
See every sector, industry and share-change value
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

THNR ETF All Holdings

THNR holdings total 22 positions. The top 10 holdings account for 61.7% of the fund, led by Novo-Nordisk A/S-Spons Adr at 9.3%, Eli Lilly & Co. at 8.9%, Regeneron Pharmaceuticals, Inc. at 6.0%.

THNR portfolio concentration is relatively high, with the top 10 representing 61.7% of total assets. The largest sector exposure is Health Care at 73.9%.

THNR sectors provide a detailed breakdown. THNR overlap shows how holdings compare to other funds in your portfolio.

THNR ETF Holdings

22 of 22 holdings

  • 1

    Novo-Nordisk A/S-Spons Adr

    NVO:OSHealth Care
    9.35%
  • 2

    Eli Lilly & Co.

    LLYHealth Care
    8.90%
  • 3

    Regeneron Pharmaceuticals, Inc.

    REGNHealth Care
    5.96%
  • 4

    Innovent Biologics, Inc.

    1801:KYUnknown
    5.83%
  • 5

    CSPC Pharmaceutical Group Limited Shs

    1093:HKHealth Care
    5.44%
  • 6

    Amgen Inc.

    AMGNHealth Care
    5.39%
  • 7

    Scholar Rock Holding Corp

    SRRKHealth Care
    5.34%
  • 8

    Arrowhead Pharmaceuticals Inc

    ARWRHealth Care
    5.31%
  • 9

    Roche Holding Ltd. Ordinary Shares - Bearer Shares

    RO:SMUnknown
    5.20%
  • 10

    Abbvie Inc.

    ABBVHealth Care
    4.94%
  • 11

    Hims & Hers Health Inc

    HIMSHealth Care
    4.93%
  • 12

    Merck & Company Inc

    MRKHealth Care
    4.80%
  • 13

    Pfizer Inc

    PFEHealth Care
    4.74%
  • 14

    Viking Therapeutics Inc Com

    VKTXHealth Care
    4.69%
  • 15

    Chugai Pharmaceutical Co. Ltd. Com Stk

    4519:JPUnknown
    4.19%
  • 16

    Developed Markets Astrazeneca Plc Sponsored Adr

    AZN:LNHealth Care
    4.11%
  • 17

    Zealand Pharma A/S Ordinary Shares

    ZEAL:COUnknown
    3.91%
  • 18

    Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H

    1276:SHUnknown
    2.23%
  • 19

    Hanmi Pharm Co Ltd

    128940:KRUnknown
    2.10%
  • 20

    Kailera Therapeutics Inc

    KLRAUnknown
    2.02%
  • 21

    Invesco Government & Agency Portfolio, Institutional Class

    AGPXXFinancials
    0.37%
  • 22

    Freddie Mac Pool 5 06/01/2053

    Other
    0.24%